156 related articles for article (PubMed ID: 7490133)
1. Inhibition of activation of human T lymphocytes by the complement C1 esterase inhibitor.
Eriksson H; Sjögren HO
Immunology; 1995 Oct; 86(2):304-10. PubMed ID: 7490133
[TBL] [Abstract][Full Text] [Related]
2. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
3. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
Ijichi S; Yamano Y; Osame M; Hall WW
Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
[TBL] [Abstract][Full Text] [Related]
4. Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.
Hack CE; Ogilvie AC; Eisele B; Jansen PM; Wagstaff J; Thijs LG
Prog Clin Biol Res; 1994; 388():335-57. PubMed ID: 7831367
[TBL] [Abstract][Full Text] [Related]
5. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
Windfuhr JP; Alsenz J; Loos M
Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
Salvesen B; Nielsen EW; Harboe M; Saugstad OD; Mollnes TE
Mol Immunol; 2009 Feb; 46(4):688-94. PubMed ID: 18950866
[TBL] [Abstract][Full Text] [Related]
7. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
Levy NJ; Kasper DL
J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
[TBL] [Abstract][Full Text] [Related]
8. Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation.
Kraft M; Filsinger S; Krämer KL; Kabelitz D; Hänsch GM; Schoels M
Immunology; 1995 Jul; 85(3):461-6. PubMed ID: 7558136
[TBL] [Abstract][Full Text] [Related]
9. Modulation of lymphocyte proliferative responses to mitogens and antigens by complement components C1, C4 and C2.
Laham MN; Caldwell JR; Panush RS
J Clin Lab Immunol; 1982 Oct; 9(1):39-47. PubMed ID: 6983586
[TBL] [Abstract][Full Text] [Related]
10. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
Thielmann M; Marggraf G; Neuhäuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
[TBL] [Abstract][Full Text] [Related]
11. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury.
Buerke M; Prüfer D; Dahm M; Oelert H; Meyer J; Darius H
J Pharmacol Exp Ther; 1998 Jul; 286(1):429-38. PubMed ID: 9655888
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of antigen-specific T cell activation by staphylococcal enterotoxins.
Dowd JE; Jenkins RN; Karp DR
J Immunol; 1995 Feb; 154(3):1024-31. PubMed ID: 7822779
[TBL] [Abstract][Full Text] [Related]
13. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors.
Al-Daccak R; Mehindate K; Damdoumi F; Etongué-Mayer P; Nilsson H; Antonsson P; Sundström M; Dohlsten M; Sékaly RP; Mourad W
J Immunol; 1998 Jan; 160(1):225-32. PubMed ID: 9551975
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the binding ability and the rate of activation of the complement component C1.
Folkerd EJ; Gardner B; Hughes-Jones NC
Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain.
Thibodeau J; Dohlsten M; Cloutier I; Lavoie PM; Bjork P; Michel F; Léveillé C; Mourad W; Kalland T; Sékaly RP
J Immunol; 1997 Apr; 158(8):3698-704. PubMed ID: 9103433
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human T cell response to staphylococcal enterotoxin B by prior ligation of surface CD4 molecules.
Fournel S; Morel P; Revillard JP; Lizard G; Bonnefoy-Berard N
Cell Immunol; 1993 Aug; 150(1):194-204. PubMed ID: 8102087
[TBL] [Abstract][Full Text] [Related]
19. C1-esterase inhibitor and a novel peptide inhibitor improve contractile function in reperfused skeletal muscle.
Toomayan GA; Chen LE; Jiang HX; Qi WN; Seaber AV; Frank MM; Urbaniak JR
Microsurgery; 2003; 23(6):561-7. PubMed ID: 14705072
[TBL] [Abstract][Full Text] [Related]
20. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
